tradingkey.logo
tradingkey.logo
Search

Niagen Bioscience Inc

NAGE
Add to Watchlist
3.430USD
+0.100+3.00%
Close 07/02, 13:00ETQuotes delayed by 15 min
273.42MMarket Cap
14.69P/E TTM

More Details of Niagen Bioscience Inc Company

Niagen Bioscience, Inc., formerly Chromadex Corp., is a global bioscience company. It is engaged in research on nicotinamide adenine dinucleotide (NAD+), an essential coenzyme that is a key regulator of cellular metabolism and is found in every cell of the human body. The Company’s Consumer Products segment provides finished dietary supplement products that contain the Company's proprietary ingredients directly to consumers and distributors and offers NAD+ test kits exclusively to healthcare practitioners. The Ingredients segment develops and commercializes proprietary-based ingredient technologies, including food-grade Niagen and pharmaceutical-grade Niagen, and supplies these ingredients as raw materials to the manufacturers of consumer products and United States FDA-registered 503B outsourcing facilities, respectively. The Analytical Reference Standards and Services segment offers the supply of phytochemical reference standards and other research and development services.

Niagen Bioscience Inc Info

Ticker SymbolNAGE
Company nameNiagen Bioscience Inc
IPO dateJun 25, 2007
CEOFried (Robert N)
Number of employees104
Security typeOrdinary Share
Fiscal year-endJun 25
Address10900 Wilshire Blvd Suite 600
CityLOS ANGELES
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited States of America
Postal code90024
Phone13103886706
Websitehttps://www.niagenbioscience.com/
Ticker SymbolNAGE
IPO dateJun 25, 2007
CEOFried (Robert N)

Company Executives of Niagen Bioscience Inc

Name
Name/Position
Position
Shareholding
Change
Mr. Ozan Pamir
Mr. Ozan Pamir
Chief Financial Officer
Chief Financial Officer
9.59K
+23.15%
Mr. Steven D. (Steve) Rubin, Esq., J.D.
Mr. Steven D. (Steve) Rubin, Esq., J.D.
Lead Independent Director
Lead Independent Director
7.00K
--
Mr. Carlos Luis Lopez
Mr. Carlos Luis Lopez
Senior Vice President, General Counsel
Senior Vice President, General Counsel
2.25K
--
Mr. Frank L. Jaksch, Jr.
Mr. Frank L. Jaksch, Jr.
Chairman of the Board
Chairman of the Board
--
--
Mr. Robert N. (Rob) Fried
Mr. Robert N. (Rob) Fried
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Ms. Wendy Yu
Ms. Wendy Yu
Independent Director
Independent Director
--
--
Mr. Gary Ng
Mr. Gary Ng
Independent Director
Independent Director
--
--
Ms. Kristin Patrick
Ms. Kristin Patrick
Independent Director
Independent Director
--
--
Ms. Ann Cohen
Ms. Ann Cohen
Independent Director
Independent Director
--
--
Mr. Hamed Shahbazi
Mr. Hamed Shahbazi
Independent Director
Independent Director
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Ozan Pamir
Mr. Ozan Pamir
Chief Financial Officer
Chief Financial Officer
9.59K
+23.15%
Mr. Steven D. (Steve) Rubin, Esq., J.D.
Mr. Steven D. (Steve) Rubin, Esq., J.D.
Lead Independent Director
Lead Independent Director
7.00K
--
Mr. Carlos Luis Lopez
Mr. Carlos Luis Lopez
Senior Vice President, General Counsel
Senior Vice President, General Counsel
2.25K
--
Mr. Frank L. Jaksch, Jr.
Mr. Frank L. Jaksch, Jr.
Chairman of the Board
Chairman of the Board
--
--
Mr. Robert N. (Rob) Fried
Mr. Robert N. (Rob) Fried
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Ms. Wendy Yu
Ms. Wendy Yu
Independent Director
Independent Director
--
--

FAQs

Who are the top five shareholders of Niagen Bioscience Inc?

The top five shareholders of Niagen Bioscience Inc are: Mr. Ozan Pamir